COMPANY

Actuate Therapeutics

Keywords: oncology cancer

Location: Fort Worth, TX · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Public offering · $17.25M · announced Sep 11, 2025 Company release ↗
Source quote
- Sep 11, 2025 · Company release ↗
  “(“Actuate” … kinase-3 beta (GSK-3β), today announced the closing of its $17.25 million underwritten public offering of 2,464,286 shares of its common stock, including 321,428 additional shares of its common stock issued pursuant to the full exercise by the underwriter of its over-allotment option”

Raises announced in these releases: $17.25M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Sep 11, 2025 Raise Follow-on offering: $17.25M (total, as published), announced Sep 11, 2025. Source: company release on GlobeNewswire. source ↗
Sep 11, 2025 Raise Public offering · $17.25M source ↗

Raised: $17.2M. Last 2 years.

Sep 11, 2025 Follow-on offering: $17.25M (total, as published), announced Sep 11, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2025-07-07 Raise Private raise (SEC Form D): $4.7M sold of $9.3M offered; issuer “ACTUATE THERAPEUTICS, INC.”. Verified from the SEC filing. SEC filing ↗
2025-04-10 Raise Private raise (SEC Form D): amount sold not stated; issuer “ACTUATE THERAPEUTICS, INC.”. Verified from the SEC filing. SEC filing ↗